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Abstract
Endoscopic ultrasonography-guided fine needle aspiration 
(EUS-FNA) is a useful and relatively safe tool for the 
diagnosis and staging of pancreatic cancer. However, 
there have recently been several reports of tumor seeding 
after EUS-FNA of adenocarcinomas. A 78-year-old man 
was admitted to our hospital due to upper gastric pain. 
Examinations revealed a 20 mm mass in the pancreatic 
body, for which EUS-FNA was performed. The cytology 
of the lesion was adenocarcinoma, and the stage of the 
cancer was T3N0M0. The patient underwent surgery with 
curative intent, followed by adjuvant chemotherapy with 
S-1. An enlarging gastric submucosal tumor was found 
on gastroscopy at 28 mo after surgery accompanied by a 
rising level of CA19-9. Biopsy result was adenocarcinoma, 
consistent with a pancreatic primary tumor. Tumor 
seeding after EUS-FNA was strongly suspected. The 
patient underwent surgical resection of the gastric 
tumor with curative intent. The pathological result of 
the resected gastric specimen was adenocarcinoma with 
a perfectly matched mucin special stain result with the 
previously resected pancreatic cancer. This is the first 
case report of tumor seeding after EUS-FNA which was 
surgically resected and inspected pathologically.
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Core tip: This manuscript is the first case report about 
tumor seeding after endoscopic ultrasonography-
guided fine needle aspiration (EUS-FNA) which was 
surgically resected and inspected pathologically. 
EUS-FNA is a widely performed procedure; however, 
there are no clear guidelines indicating the selection 
of treatments in cases of tumor seeding after the 
procedure, as this adverse event is relatively rare. 
This manuscript may help in the selection of patients 
undergoing EUS-FNA, and clarifies the points we 
should be careful about after the procedure.
Tomonari A, Katanuma A, Matsumori T, Yamazaki H, Sano I, 
Minami R, Sen-yo M, Ikarashi S, Kin T, Yane K, Takahashi K, 
Shinohara T, Maguchi H. Resected tumor seeding in stomach 
wall due to endoscopic ultrasonography-guided fine needle 
aspiration of pancreatic adenocarcinoma. World J Gastroenterol 
2015; 21(27): 8458-8461  Available from: URL: http://www.
wjgnet.com/1007-9327/full/v21/i27/8458.htm  DOI: http://dx.doi.
org/10.3748/wjg.v21.i27.8458
INTRODUCTION
Endoscopic ultrasonography-guided fine needle 
aspiration (EUS-FNA) is a useful and relatively safe 
tool for the diagnosis and staging of pancreatic cancer. 
The reported complication rates of EUS-FNA are low (< 
1% in large centers[1]), and the risks of tumor seeding 
are lower compared to transcutaneous methods[2,3]. 
However, there have recently been several reports 
of tumor seeding after EUS-FNA of non-cystic solid 
adenocarcinomas[4,5]. The previously reported cases 
were all diagnosed at unresectable stages when the 
tumor seeding lesions were found. This is the first 
case report of tumor seeding after EUS-FNA which was 
surgically resected and inspected pathologically.
CASE REPORT
A 78-year-old man with persistent upper gastric pain 
was referred to our center for detailed examination. 
Computed tomography (CT) revealed a 20-mm-
diameter hypodense mass lesion in the pancreatic 
body, with an upstream dilatation of the main 
pancreatic duct (Figure 1). CA19-9 was abnormal with 
a level of 162.4 kU/mL (normal range, 0-37.0 kU/mL). 
At EUS, the patient had a 21-mm-diameter hypoechoic 
mass in the pancreatic body. EUS-FNA of the mass 
was performed using a 22-G needle (Expect, Boston 
Scientific, Natick, MA) (Figure 2). Suction was applied 
at each pass, and a total of two passes were made. 
Cytology of the lesion revealed an adenocarcinoma. 
No metastatic disease was found and the patient 
underwent surgery with curative intent.
There were no liver metastases, ascites, or 
peritoneal implantation at surgery. An intra-operative 
frozen section diagnosis of a lymph node around the 
abdominal aorta was performed, which revealed to be 
negative for metastasis. A 20-mm palpable mass was 
identified, with evidence of inflammation in the distal 
pancreas. Distal pancreatectomy and splenectomy 
were performed. Histology of the specimen revealed a 
25 mm × 25 mm mass with no lymphatic or vascular 
involvement, and the resection margins were negative 
for malignancy. There were no abnormalities in the 
spleen. The final diagnosis was T3N0M0 with an 
extension of moderately differentiated adenocarcinoma 
beyond the pancreas in the ventral direction.
The patient underwent adjuvant chemotherapy 
with S-1 starting at 2 mo after surgery. At 9 mo 
after surgery, a periodical follow-up gastroscopy 
performed at a private clinic revealed a 5-mm-diameter 
submucosal tumor at the posterior wall of the gastric 
body. The patient had no symptoms at that time. The 
private clinician who had performed the exam made 
the decision to follow the submucosal tumor, and 
gastroscopy was repeated after 2 mo, which showed 
no changes in the shape or the size of the submucosal 
tumor. At 8 mo after surgery, CA19-9 level gradually 
started to rise. Gastroscopy performed at 28 mo 
Figure 1  Computed tomography showing a 20-mm mass lesion in the 
pancreatic body (arrow).
Figure 2  Endoscopic ultrasonography-guided fine needle aspiration of 
the 20-mm hypoechoic mass lesion was performed using a 22-G needle.
8460 July 21, 2015|Volume 21|Issue 27|WJG|www.wjgnet.com
after surgery revealed an increase in the size of the 
submucosal tumor, and at this point, the patient was 
referred to our center for further examinations (Figure 
3). Histology of the lesion indicated adenocarcinoma, 
consistent with a pancreatic primary tumor. CT showed 
a 28-mm submucosal tumor adjacent to the pancreatic 
resection site (Figure 4). There were no apparent 
metastatic lesions, and the patient underwent surgery 
with curative intent.
Subtotal gastrectomy was performed. Histology of 
the specimen revealed a 32 mm × 30 mm submucosal 
tumor, consisting of moderately to well differentiated 
adenocarcinoma (Figure 5). The specimen was positive 
for vascular and lymphatic involvement. Mucin special 
stain results for the resected stomach specimen were 
MUC1 positive, MUC2 negative, MUC5AC positive, and 
MUC6 negative. Mucin special stains for the previously 
resected specimen of the pancreas were additionally 
performed. The results were MUC1 positive, MUC2 
negative, MUC5AC positive, and MUC6 negative, which 
were perfectly compatible with the resected stomach 
lesion.
DISCUSSION
Although gastric recurrence of adenocarcinoma may 
occur by direct invasion, the resected specimen in 
this case strongly suggests tumor seeding after EUS-
FNA due to the facts that its origin is submucosal, 
and the mucin special stains were perfectly matched 
to the original pancreatic cancer. There has been 
a retrospective study which reported that there is 
no association with an increased rate of gastric or 
peritoneal cancer recurrence following EUS-FNA[6]. 
However, it is also true that there have been several 
reports of tumor seeding after the procedure. This 
may be due to the rate of tumor seeding after EUS-
FNA being so low that it is statistically difficult to 
establish an association between the procedure and 
the recurrence. Also, unresected recurrences are 
difficult to distinguish between direct invasion and tract 
seeding, and this may contribute to the fact that the 
Figure 3  Submucosal tumor at the gastric body increased in size at 28 mo 
after surgery.
Figure 4  Computed tomography shows the submucosal tumor located 
adjacent to the pancreatic resection site.
Figure 5  Resected specimen of the needle tract seeding in the stomach. 
The tumor is 25 mm × 25 mm, with a whitish appearance (A). The tumor is 
located in the submucosal layer (B). Hematoxylin and eosin staining.
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reported incidence rate of seeding is so low.
EUS-FNA is an important procedure usually per-
formed pre-operatively to determine the indication 
of surgical resection of the tumor. The reported inci-
dences of tumor seeding are so low that the advantage 
of performing EUS-FNA before surgery may not 
outweigh the risk of needle tract seeding. However, 
as the number of EUS-FNA is expected to continue to 
increase, the possibility of post-procedural EUS-FNA 
needle tract seeding should always be minded. In cases 
when surgical resection will not include the needle tract 
(e.g., resection of the tail/body of the pancreas), EUS-
FNA should be either avoided, or the number of needle 
passes limited. When EUS-FNA is indispensable for the 
diagnosis and treatment of the disease, excision of the 
needle tract path may be necessary for consideration. 
When this is not possible, close periodical examinations 
including gastroscopy should be scheduled for patients 
who undergo EUS-FNA without needle tract resection.
COMMENTS
Case characteristics
A case of tumor seeding of a pancreatic adenocarcinoma in the stomach wall 
at the endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) 
puncture site, was treated surgically and inspected pathologically.
Clinical diagnosis
A submucosal tumor of the stomach wall found at a periodical post-operative 
endoscopy was suspected as a seeding tumor recurrence of the resected 
pancreatic adenocarcinoma.
Differential diagnosis
Pancreatic adenocarcinoma metastasis or a new completely separate 
submucosal lesion such as a GIST.
Laboratory diagnosis
Periodical tumor marker follow-ups were performed, showing a gradual CA19-9 increase.
Imaging diagnosis
Periodical gastroscopy revealed a lesion in a submucosal tumor form at the 
puncture site of the EUS-FNA which was performed preoperatively.
Pathological diagnosis
Endoscopically performed biopsy revealed an adenocarcinoma, leading to the 
suspicion of a tumor recurrence as a seeding after EUS-FNA.
Treatment
Subtotal gastrectomy was performed, and mucin special stain results for the 
resected stomach specimen were perfectly compatible with the previously 
resected pancreatic adenocarcinoma.
Experiences and lessons
When EUS-FNA is indispensable for the diagnosis and treatment of the disease, 
excision of the needle tract path may be necessary for consideration. When this 
is not possible, close periodical examinations including gastroscopy should be 
scheduled for patients who undergo EUS-FNA without needle tract resection.
Peer-review
This is a rare case of tumor recurrence of a pancreatic adenocarcinoma as 
seeding after EUS-FNA, treated surgically and inspected pathologically. 
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